Genetic Profiling

Many diseases such as osteoporosis, thrombosis, cancer and heart disease have a strong genetic component. Many of these diseases are also preventable or easily treated if detected early. Genetic Profiling empowers you with an additional tool that enables a proactive approach in your health-care. The more you know and the earlier you know about your individual risks, the better prepared you will be to develop health-enhancing strategies with healthcare professionals. You can make the necessary changes in your environment such as diet, nutrition, exercise, and other behaviors that are designed to improve your quality of life. Predictive genetic testing or genetic profiling panels access risk factors that help determine the probability that an asymptomatic (healthy) individual with or without a family history of a certain disease might develop a disease.

Glaucoma & Macular Degeneration DNA Analysis

Glaucoma is the second leading cause of blindness worldwide. At least 2.5 million people in the United States are at increased risk for Glaucoma. Age-related Macular Degeneration is the leading cause of legal blindness in the United States for individuals over 55 years of age.

If an individual has a genetic profile that predisposes him or her to Glaucoma, the disease can be treated if identified early enough. Once the disease has progressed, it is very difficult to treat or to reverse. While Glaucoma is not preventable, early intervention is the key to successful treatment since diagnosing Glaucoma is a matter of vigilance and regular eye exams. With Macular Degeneration, individuals can take preventative action to delay or avoid the possible onset. The disease is stress related and complicated by dietary deficiencies and other risk factors. Glaucoma & Macular Degeneration DNA Analysis is designed to help identify the risk factors that can adversely affect healthy eyesight.

Age related macular degeneration is the leading cause of blindness for people over 55 years of age in the US and glaucoma is the second leading cause of blindness. Diagnosing Glaucoma is a matter of vigilance and regular eye exams. If an individual has a genetic profile that predisposes him or her to Glaucoma, the disease can be treated if identified early enough. Once the disease has progressed, it is very difficult to treat or to reverse. With Macular Degeneration, individuals can take preventative action to delay or avoid the possible onset. The disease is stress related and complicated by dietary deficiencies and other risk factors. While Glaucoma is not preventable, early intervention is the key to successful treatment.

Optimum Athletic Performance DNA Analysis

What your DNA can tell about your Athletic Performance potential and risk of Sports Injuries: A number of genes play a role in athletic performance. Scientific evidence suggests that muscle growth, cardiac output and other factors influence physical performance and are associated with which version of certain genes you carry. Other genes help identify weaknesses in certain areas such as bone strength and neurological predispositions that can lead to sports related injuries and long term disabilities.

Athletic Performance Panel Can Tell You.
The CyGene panel for athletic performance was put together based on the latest scientific evidence of genes related to athletic performance potential and sports related injuries. Find out if your DNA predisposes you to perform better at endurance or strength athletics. This will allow you to optimize your training for peak performance. You may also be predisposed to neurological damage or injury to your skeletal system by performing certain activities. Genetically some athletes seem to be built for speed and some for endurance. The U.S. Military has been selecting candidates for their elite troops such as the Army Rangers and Navy Seals using these types of tests. These methods are aimed at saving time and money when it comes to athletic training. They promote implementing optimal personalized training, while reducing the risk of permanent physical injury. This DNA test can not only help determine if you have the potential for Olympic size success but also tell you if you are more susceptible to sports related injury.

Genes play a role in every aspect of your individual characteristics and have been shown to have an effect on athletic performance. Scientific evidence suggests that muscle growth, cardiac output and other factors influence physical performance and are associated with certain versions of genes you may carry. Other genes help identify weaknesses in certain areas such as bone strength and neurological predispositions that can lead to sports related injuries and long term disabilities.

Optimum Athletic Performance DNA Analysis can help you assess what type of sport you are genetically wired for and what sports put you at risk of physical or neurological injury.

Thrombosis DNA Analysis

According to the American Heart Association, Deep Vein Thrombosis (DVT) occurs in about 2 million Americans every year. More people suffer from DVT annually than heart attack and stroke. Up to 600,000 people are hospitalized in the U.S. each year for DVT. Fatal Pulmonary Embolism may be the most common preventable cause of hospital death in the United States.

According to the American Heart Association, up to 2 million Americans are affected annually by Deep Vein Thrombosis (DVT), 600,000 of which are hospitalized. Of those who develop a Pulmonary Embolism (PE) from DVT, up to 200,000 will die each year. More people die in the United States from PE than breast cancer and AIDS combined. These significant statistics do not account for DVT related stroke or heart attack. DVT is the leading cause of maternal death during child birth.

This test panel examines a number of genetic factors that may indicate a predisposition to Thrombosis or blood clotting problems. These gene mutations combined with other factors such as smoking, frequent air travel, sustaining a sports injury, hospitalization – and, in the case of women, the use of oral contraceptives, hormone replacement therapy or pregnancy – could put an individual at a much higher risk of DVT. The more risk factors an individual has, the greater the likelihood of developing DVT.

Thrombosis or DVT is a preventable condition and a Thrombosis DNA Analysis can help you make lifestyle changes or a candidate for medication, if you are at risk.

Find out if your DNA puts you at risk. Any one of four DNA markers combined with any of the following may put you at high risk:
  • Cancer
  • Certain heart or respiratory diseases
  • Advanced age
  • Acute medical illness with restricted mobility
  • Hospitalization
  • Obesity
  • Stroke
  • Patients undergoing major surgery, such as joint replacements, who remain immobile in bed after an operation
  • Pregnancy
  • Use of birth control pills
  • Postmenopausal hormone replacement therapy
  • Restricted mobility caused by long-distance travel
  • Sports Injury or other trauma

Osteoporosis DNA Analysis

Why Thrombosis DNA Analysis is important to you.
According to the American Heart Association, Deep Vein Thrombosis (DVT) occurs in about 2 million Americans every year. More people suffer from DVT annually than heart attack and stroke. Up to 600,000 people are hospitalized in the U.S. each year for DVT. Fatal Pulmonary Embolism may be the most common preventable cause of hospital death in the United States. According to the American Heart Association, up to 2 million Americans are affected annually by Deep Vein Thrombosis (DVT), 600,000 of which are hospitalized. Of those who develop a Pulmonary Embolism (PE) from DVT, up to 200,000 will die each year. More people die in the United States from PE than breast cancer and AIDS combined. These significant statistics do not account for DVT related stroke or heart attack. DVT is the leading cause of maternal death during child birth.

This test panel examines a number of genetic factors that may indicate a predisposition to Thrombosis or blood clotting problems. These gene mutations combined with other factors such as smoking, frequent air travel, sustaining a sports injury, hospitalization – and, in the case of women, the use of oral contraceptives, hormone replacement therapy or pregnancy – could put an individual at a much higher risk of DVT. The more risk factors an individual has, the greater the likelihood of developing DVT. Thrombosis or DVT is a preventable condition and a Thrombosis DNA Analysis can help you make lifestyle changes or a candidate for medication, if you are at risk.

Find out if your DNA puts you at risk.
One out of two women and one in eight men over age 50 will have an osteoporosis-related fracture in their lifetime. 10% of African-American women over age 50 have osteoporosis; an additional 30% have low bone density that puts them at risk of developing osteoporosis. Significant risk has been reported in people of all ethnic backgrounds. While osteoporosis is often thought of as an older person's disease, it can strike at any age. Osteoporosis is responsible for more than 1.5 million fractures annually, including: 300,000 hip fractures; and approximately 700,000 vertebral fractures 250,000 wrist fractures 300,000 fractures at other sites.

Why Bone Health DNA Analysis is Important to you.
Osteoporosis is a major public health threat for more than 28 million Americans, 80 percent of whom are women. In the U.S. today, 10 million individuals already have the disease and 18 million more have low bone mass, placing them at increased risk for osteoporosis. The estimated national direct expenditures (hospitals and nursing homes) for osteoporotic and associated fractures is $13.8 billion ($38 million each day) and the cost is rising.

The National Osteoporosis Foundation describes Osteoporosis as “a debilitating disease that can be prevented and treated.” Osteoporosis is a disease that causes bones to become fragile and more likely to break. If not prevented, or if left untreated, Osteoporosis can progress painlessly until a bone breaks. These broken bones, also known as fractures, occur typically in the hip, spine, and wrist. Osteoporosis already affects 28 million Americans. The estimated national direct expenditures (hospitals and nursing homes) for related fractures are $13.8 billion per year ($38 million each day) and the cost is rising.

Osteoporosis is a preventable disease. Osteoporosis DNA Analysis can iden­tify if a person is at risk of the disease and help guide them through their available options.



To get started, please visit our HOW TO APPLY page and submit the Preliminary Application Form. This will allow our doctors to pre-analyze your case.

 

"Our mission and passion is to plant seeds of wisdom, knowledge and understanding for the healing of our patients"

Villa Natura
Medical Institute